Applied Genetic (AGTC) Peer Comparison

$0.39

$0.00 (0.00%)

As on 09-Dec-2022 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Edit

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Market cap ($ Mln)	27	491
Revenue ($ Mln)	0	--
Net Profit ($ Mln)	-70.23	-92.59
Net Margin (%)	-21,610.46	-14,862.28
RoE (%)	-217.20	-47.50
Price to Earnings	--	--
Price-To-Book	1.51	2.72

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Operating Revenue	0.33	0.00
Cost of Revenue	--	--
Gross Profit	--	--
Operating Expenses	66.50	86.82
Operating Profit (EBIT)	-66.18	-86.82
Other Income	--	0.15
Profit before Tax	-68.75	-86.67
Provision for Tax	-68.85	--
Profit after Tax (Net Income)	-68.94	-86.67
Minority Interest	--	--
Consolidated Profit	-68.94	-86.67

Liabilities ($ Mln)

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Shareholder's Funds	29.48	233.65
Minority Interest	--	--
Non-Current Liabilities	12.00	28.30
Current Liabilities	25.21	16.80
Total Liabilities	66.68	278.76

Assets ($ Mln)

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Non-Current Assets	17.12	42.59
Current Assets	49.56	236.16
Total Assets	66.68	278.76
Total Debt*	22.47	28.98
Net Current Assets	24.35	219.36

Cashflow ($ Mln)

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Cash From Operating Activities	-65.75	-63.73
Cash Flow from Investing Activities	-0.01	117.62
Cash from Financing Activities	7.08	0.22
Net Cash Inflow / Outflow	--	54.11

Ratios

Profitability Ratios

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
ROCE (%)	-84.99	-29.56
ROE (%)	-119.60	-31.85
ROA (%)	-71.20	-28.32
EBIT Margin (%)	--	--
Net Margin (%)	-21,213.23	-57,780.67
Cash Profit Margin (%)	--	--

Growth Ratios

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Revenue Growth (%)	-0.35	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	-19.22	-78.34
EPS Growth (%)	0.13	0.06
Book Value Growth (%)	--	--

Valuation Ratios

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Price / Earnings	-0.50	-3.33
Price / Book Value	1.18	1.24
Dividend Yield (%)	--	--
EV/EBITDA	-0.17	-1.03
Market Cap ($ Cr)	--	--

Solvency Ratios

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Debt to Equity	0.76	0.12
Short term debt to equity ratio	0.36	0.00
Current Ratio	1.97	14.06
Quick Ratio	--	--
Interest Coverage	-24.78	--

Operating Efficiency Ratios

	Applied Genetic (AGTC)	AkouosÂ Inc (AKUS)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	0.00	--
Inventory Days	--	--
Payable days	--	--
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly